Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Rickels

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 26, 2018
Benzodiazepines in anxiety disorders: Reassessment of usefulness and safetyKarl Rickels, Hans Juergen Moeller
Journal of Clinical Psychopharmacology|July 17, 2007
Why do clinical trials fail?Karl Rickels, Donald S Robinson
Journal of Clinical Psychopharmacology|September 7, 2004
A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorderKarl Rickels, Richard Mangano, Arifulla Khan
Personalized Medicine|May 24, 2018
Vilazodone, a novel, dual-acting antidepressant: current status, future promise and potential for individualized treatment of depressionKarl Rickels, Maria Athanasiou, Carol Reed
Journal of Clinical Psychopharmacology|April 2, 2019
The Course of Adverse Events in Venlafaxine XR Treatment in Generalized Anxiety DisorderKarl Rickels, Robert Gallop, Sean Cleary
JAMA Psychiatry|April 30, 2015
Benzodiazepines in Anxiety DisordersGiovanni A Fava, Richard Balon, Karl Rickels
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|June 5, 2015
Need for a realistic appraisal of benzodiazepinesRichard Balon, Giovanni A Fava, Karl Rickels
The Journal of Clinical Psychiatry|January 24, 2006
Remission of generalized anxiety disorder: a review of the paroxetine clinical trials databaseKarl Rickels, Moira Rynn, Malini Iyengar, et al.
Human Psychopharmacology|May 10, 2013
Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorderAlissa J Cooper, Karl Rickels, Falk W Lohoff
Journal of Clinical Psychopharmacology|September 15, 2005
Open-label pilot study of ziprasidone for refractory generalized anxiety disorderSteven H Snyderman, Moira A Rynn, Karl Rickels
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 26, 2018
Benzodiazepines in anxiety disorders: Reassessment of usefulness and safetyKarl Rickels, Hans Juergen Moeller
Journal of Clinical Psychopharmacology|July 17, 2007
Why do clinical trials fail?Karl Rickels, Donald S Robinson
Journal of Clinical Psychopharmacology|September 7, 2004
A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorderKarl Rickels, Richard Mangano, Arifulla Khan
Personalized Medicine|May 24, 2018
Vilazodone, a novel, dual-acting antidepressant: current status, future promise and potential for individualized treatment of depressionKarl Rickels, Maria Athanasiou, Carol Reed
Journal of Clinical Psychopharmacology|April 2, 2019
The Course of Adverse Events in Venlafaxine XR Treatment in Generalized Anxiety DisorderKarl Rickels, Robert Gallop, Sean Cleary
JAMA Psychiatry|April 30, 2015
Benzodiazepines in Anxiety DisordersGiovanni A Fava, Richard Balon, Karl Rickels
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|June 5, 2015
Need for a realistic appraisal of benzodiazepinesRichard Balon, Giovanni A Fava, Karl Rickels
The Journal of Clinical Psychiatry|January 24, 2006
Remission of generalized anxiety disorder: a review of the paroxetine clinical trials databaseKarl Rickels, Moira Rynn, Malini Iyengar, et al.
Human Psychopharmacology|May 10, 2013
Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorderAlissa J Cooper, Karl Rickels, Falk W Lohoff
Journal of Clinical Psychopharmacology|September 15, 2005
Open-label pilot study of ziprasidone for refractory generalized anxiety disorderSteven H Snyderman, Moira A Rynn, Karl Rickels
Pageof 7